Indantadol: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{Short description|An overview of the drug Indantadol}} | |||
{{Drugbox | |||
| verifiedrevid = 123456789 | |||
| image = Indantadol.svg | |||
| image_size = 250px | |||
| image_alt = Chemical structure of Indantadol | |||
}} | |||
'''Indantadol''' is a pharmaceutical compound that has been investigated for its potential use as an analgesic. It is known for its dual mechanism of action, which includes both [[NMDA receptor]] antagonism and [[monoamine oxidase]] inhibition. This unique combination of effects makes it a subject of interest in the treatment of [[chronic pain]] conditions. | |||
Indantadol | |||
== | ==Mechanism of Action== | ||
Indantadol | Indantadol functions primarily through two mechanisms: | ||
== | ===NMDA Receptor Antagonism=== | ||
[[File:Indantadol.svg|thumb|right|Chemical structure of Indantadol]] | |||
Indantadol acts as an antagonist at the [[N-methyl-D-aspartate receptor|NMDA receptor]], which is a subtype of [[glutamate receptor]]. By inhibiting these receptors, Indantadol can reduce the excitatory neurotransmission that is often associated with chronic pain states. NMDA receptor antagonists are known to play a role in diminishing [[central sensitization]] and [[neuropathic pain]]. | |||
== | ===Monoamine Oxidase Inhibition=== | ||
Indantadol | In addition to its effects on NMDA receptors, Indantadol also inhibits [[monoamine oxidase]] (MAO), an enzyme responsible for the breakdown of [[monoamines]] such as [[serotonin]], [[dopamine]], and [[norepinephrine]]. By inhibiting MAO, Indantadol may increase the levels of these neurotransmitters in the brain, contributing to its analgesic and potentially antidepressant effects. | ||
== | ==Pharmacokinetics== | ||
* [[ | The pharmacokinetic profile of Indantadol includes its absorption, distribution, metabolism, and excretion. As with many drugs, these parameters can influence its efficacy and safety profile. | ||
===Absorption=== | |||
Indantadol is typically administered orally, and its absorption can be affected by factors such as food intake and gastrointestinal pH. | |||
===Distribution=== | |||
Once absorbed, Indantadol is distributed throughout the body. It is known to cross the [[blood-brain barrier]], which is essential for its central nervous system effects. | |||
===Metabolism=== | |||
Indantadol is metabolized primarily in the liver. The specific pathways and metabolites involved in its metabolism are subjects of ongoing research. | |||
===Excretion=== | |||
The excretion of Indantadol occurs through renal and hepatic pathways. Understanding its excretion is important for dosing considerations, especially in patients with renal or hepatic impairment. | |||
==Clinical Applications== | |||
Indantadol has been studied for its potential use in various pain conditions, including: | |||
===Chronic Pain=== | |||
Chronic pain, such as that associated with [[fibromyalgia]] or [[neuropathic pain]], may be alleviated by the dual action of Indantadol on NMDA receptors and monoamine oxidase. | |||
===Potential Antidepressant Effects=== | |||
Due to its action on monoamine levels, Indantadol may also have potential as an antidepressant, although this application requires further investigation. | |||
==Side Effects== | |||
As with any medication, Indantadol may cause side effects. Common side effects include: | |||
* [[Nausea]] | |||
* [[Dizziness]] | |||
* [[Headache]] | |||
More serious side effects, although rare, may include: | |||
* [[Hypertension]] | |||
* [[Serotonin syndrome]] | |||
==Related Pages== | |||
* [[NMDA receptor antagonist]] | |||
* [[Monoamine oxidase inhibitor]] | * [[Monoamine oxidase inhibitor]] | ||
* [[ | * [[Chronic pain management]] | ||
[[Category:Analgesics]] | [[Category:Analgesics]] | ||
[[Category:NMDA receptor antagonists]] | |||
[[Category:Monoamine oxidase inhibitors]] | [[Category:Monoamine oxidase inhibitors]] | ||
Latest revision as of 03:50, 13 February 2025
An overview of the drug Indantadol
| Indantadol | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Indantadol is a pharmaceutical compound that has been investigated for its potential use as an analgesic. It is known for its dual mechanism of action, which includes both NMDA receptor antagonism and monoamine oxidase inhibition. This unique combination of effects makes it a subject of interest in the treatment of chronic pain conditions.
Mechanism of Action[edit]
Indantadol functions primarily through two mechanisms:
NMDA Receptor Antagonism[edit]
Indantadol acts as an antagonist at the NMDA receptor, which is a subtype of glutamate receptor. By inhibiting these receptors, Indantadol can reduce the excitatory neurotransmission that is often associated with chronic pain states. NMDA receptor antagonists are known to play a role in diminishing central sensitization and neuropathic pain.
Monoamine Oxidase Inhibition[edit]
In addition to its effects on NMDA receptors, Indantadol also inhibits monoamine oxidase (MAO), an enzyme responsible for the breakdown of monoamines such as serotonin, dopamine, and norepinephrine. By inhibiting MAO, Indantadol may increase the levels of these neurotransmitters in the brain, contributing to its analgesic and potentially antidepressant effects.
Pharmacokinetics[edit]
The pharmacokinetic profile of Indantadol includes its absorption, distribution, metabolism, and excretion. As with many drugs, these parameters can influence its efficacy and safety profile.
Absorption[edit]
Indantadol is typically administered orally, and its absorption can be affected by factors such as food intake and gastrointestinal pH.
Distribution[edit]
Once absorbed, Indantadol is distributed throughout the body. It is known to cross the blood-brain barrier, which is essential for its central nervous system effects.
Metabolism[edit]
Indantadol is metabolized primarily in the liver. The specific pathways and metabolites involved in its metabolism are subjects of ongoing research.
Excretion[edit]
The excretion of Indantadol occurs through renal and hepatic pathways. Understanding its excretion is important for dosing considerations, especially in patients with renal or hepatic impairment.
Clinical Applications[edit]
Indantadol has been studied for its potential use in various pain conditions, including:
Chronic Pain[edit]
Chronic pain, such as that associated with fibromyalgia or neuropathic pain, may be alleviated by the dual action of Indantadol on NMDA receptors and monoamine oxidase.
Potential Antidepressant Effects[edit]
Due to its action on monoamine levels, Indantadol may also have potential as an antidepressant, although this application requires further investigation.
Side Effects[edit]
As with any medication, Indantadol may cause side effects. Common side effects include:
More serious side effects, although rare, may include:
